rs147025508

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001611.5(ACP5):​c.814C>T​(p.Arg272Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00413 in 1,614,120 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R272H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0033 ( 2 hom., cov: 31)
Exomes 𝑓: 0.0042 ( 21 hom. )

Consequence

ACP5
NM_001611.5 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:10

Conservation

PhyloP100: 0.612

Publications

6 publications found
Variant links:
Genes affected
ACP5 (HGNC:124): (acid phosphatase 5, tartrate resistant) This gene encodes an iron containing glycoprotein which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. [provided by RefSeq, Aug 2008]
ZNF627 (HGNC:30570): (zinc finger protein 627) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0074237585).
BP6
Variant 19-11575174-G-A is Benign according to our data. Variant chr19-11575174-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 198455.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00334 (508/152298) while in subpopulation NFE AF = 0.00563 (383/68026). AF 95% confidence interval is 0.00516. There are 2 homozygotes in GnomAd4. There are 230 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACP5NM_001611.5 linkc.814C>T p.Arg272Cys missense_variant Exon 5 of 5 ENST00000648477.1 NP_001602.1 P13686A0A024R7F8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACP5ENST00000648477.1 linkc.814C>T p.Arg272Cys missense_variant Exon 5 of 5 NM_001611.5 ENSP00000496973.1 P13686

Frequencies

GnomAD3 genomes
AF:
0.00334
AC:
508
AN:
152180
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000748
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00314
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00283
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00563
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00315
AC:
792
AN:
251074
AF XY:
0.00321
show subpopulations
Gnomad AFR exome
AF:
0.000370
Gnomad AMR exome
AF:
0.00376
Gnomad ASJ exome
AF:
0.00129
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00296
Gnomad NFE exome
AF:
0.00484
Gnomad OTH exome
AF:
0.00392
GnomAD4 exome
AF:
0.00421
AC:
6157
AN:
1461822
Hom.:
21
Cov.:
31
AF XY:
0.00410
AC XY:
2983
AN XY:
727204
show subpopulations
African (AFR)
AF:
0.000806
AC:
27
AN:
33480
American (AMR)
AF:
0.00376
AC:
168
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00157
AC:
41
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.000197
AC:
17
AN:
86258
European-Finnish (FIN)
AF:
0.00294
AC:
157
AN:
53354
Middle Eastern (MID)
AF:
0.00711
AC:
41
AN:
5768
European-Non Finnish (NFE)
AF:
0.00491
AC:
5455
AN:
1112006
Other (OTH)
AF:
0.00411
AC:
248
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
362
725
1087
1450
1812
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
194
388
582
776
970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00334
AC:
508
AN:
152298
Hom.:
2
Cov.:
31
AF XY:
0.00309
AC XY:
230
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.000746
AC:
31
AN:
41582
American (AMR)
AF:
0.00314
AC:
48
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00283
AC:
30
AN:
10606
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00563
AC:
383
AN:
68026
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
27
54
82
109
136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00364
Hom.:
3
Bravo
AF:
0.00333
TwinsUK
AF:
0.00728
AC:
27
ALSPAC
AF:
0.00545
AC:
21
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00628
AC:
54
ExAC
AF:
0.00287
AC:
348
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00578
EpiControl
AF:
0.00545

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:10
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:5
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 12, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 04, 2022
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ACP5: BP4, BS2 -

not specified Benign:2
Mar 17, 2017
Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1, BS2, BP6; This alteration has an allele frequency that is greater than expected for the associated disease, was seen in a healthy adult where full penetrance of the disorder is expected at an early age, and was reported as a benign/likely benign alteration by a reputable source (ClinVar or other correspondence from a clinical testing laboratory). -

May 01, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spondyloenchondrodysplasia with immune dysregulation Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 30, 2025
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS2, BP4 -

ACP5-related disorder Benign:1
May 03, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.34
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.53
D;D;D;D;D
Eigen
Benign
-0.12
Eigen_PC
Benign
-0.23
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.84
.;.;.;.;T
M_CAP
Benign
0.070
D
MetaRNN
Benign
0.0074
T;T;T;T;T
MetaSVM
Benign
-0.67
T
MutationAssessor
Uncertain
2.1
M;M;M;M;M
PhyloP100
0.61
PrimateAI
Benign
0.40
T
PROVEAN
Uncertain
-2.7
.;D;D;.;D
REVEL
Benign
0.21
Sift
Benign
0.055
.;T;T;.;T
Sift4G
Uncertain
0.059
.;T;T;T;T
Polyphen
0.98
D;D;D;D;D
Vest4
0.34, 0.35, 0.36
MVP
0.78
MPC
0.51
ClinPred
0.017
T
GERP RS
4.8
Varity_R
0.13
gMVP
0.62
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147025508; hg19: chr19-11685989; COSMIC: COSV108050509; COSMIC: COSV108050509; API